Hi ATL. Of course you will never understand the core issue as you keep your ears closed to anybody who disagrees with you.
It is clear the lack of patient level data for the ECA is a huge issue. Both FDA and MHRA guidences call it out. Other issues exist, but that is just overkill.
But for those who fail to understand the core issues, consider this.
NWBO announced 7 years ago that the trial was complete. All they needed to do was wrap it up and get approved. And for 7 years you ass clowns have been saying how all these new RA programs were designed to get -L approved fast.
Market Data 
Markets 
AI
